MedTrace Logo

Effects of 8-weeks Strength Training on Strength Program, Power and Agility in Traceurs

NCT05749172 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2023-08-15

No results posted yet for this study

Summary

The goal of this Randomized controlled trial was to examine effects of 8-weeks strength training program on strength, power and agility in traceurs. The main question it aims to answer is:

• To determine the effects of 8-weeks strength training program in traceurs. Participants were a given consent form and after subjects read and sign the informed consent, they were included in study according to eligibility criteria. 2 groups were included in study, Strength Group with parkour routine training was applied on group A and the control group, group B was provided with parkour routine training. Outcome was measured through different outcome measure tools.

Conditions

  • Low Back Pain

Interventions

OTHER

Strength group

4 sets of strength training exercises with 10 repetitions determined from ACSM two days a week, with a minimum of 72 hours between these days. In this exercise protocol, the movements of back squat, seated leg extension, seated leg curls, machine hip adductions, machine hip abductions, standing calf raises, back lat pulldowns, seated rows, bench press, incline bench press, biceps curls, triceps pushdowns, back press, back extension, pushup, pullup, squats and sit-ups will be performed.

OTHER

Controlled group

Two hours of parkour training for two days a week.

Sponsors & Collaborators

  • Sehat Medical Complex

    lead OTHER

Principal Investigators

  • Umair Ahmed · Ripahah International University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-18
Primary Completion
2023-05-30
Completion
2023-07-25

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05749172 on ClinicalTrials.gov